Coloplast Toekomstige groei
Future criteriumcontroles 3/6
Coloplast zal naar verwachting groeien in winst en omzet met respectievelijk 12.9% en 7.8% per jaar. De winst per aandeel zal naar verwachting groeien met 13.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 35.2% zijn.
Belangrijke informatie
12.9%
Groei van de winst
13.2%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 18.6% |
| Inkomstengroei | 7.8% |
| Toekomstig rendement op eigen vermogen | 35.2% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 18 Nov 2024 |
Recente toekomstige groei-updates
Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Nov 08
Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 23Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09Recent updates
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 13Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Nov 08Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Oct 18Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 23Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?
Aug 22Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price
Jul 17These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jun 29Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00
May 10Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Apr 26There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price
Apr 08Is Coloplast (CPH:COLO B) A Risky Investment?
Mar 21Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Jan 09Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings
Dec 22These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 04Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues
Nov 16A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Sep 30Is Coloplast (CPH:COLO B) A Risky Investment?
Jun 28Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price
Jun 10Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Mar 22Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 01These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 14Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 26Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being
Nov 25Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 11With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case
Oct 25Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)
Aug 26These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jul 27Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching
Jul 12Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?
May 23Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00
May 08Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 9/30/2027 | 34,526 | 7,522 | 7,366 | 8,630 | 14 |
| 9/30/2026 | 31,766 | 6,666 | 6,456 | 7,747 | 20 |
| 9/30/2025 | 29,282 | 5,746 | 5,508 | 6,700 | 18 |
| 9/30/2024 | 27,030 | 5,052 | 1,420 | 2,766 | N/A |
| 6/30/2024 | 26,303 | 4,967 | 1,313 | 2,599 | N/A |
| 3/31/2024 | 25,526 | 4,965 | 1,053 | 2,278 | N/A |
| 12/31/2023 | 25,001 | 4,868 | 4,285 | 5,527 | N/A |
| 9/30/2023 | 24,500 | 4,783 | 2,985 | 4,226 | N/A |
| 6/30/2023 | 24,333 | 4,784 | 3,226 | 4,485 | N/A |
| 3/31/2023 | 24,074 | 4,801 | 3,663 | 4,894 | N/A |
| 12/31/2022 | 23,515 | 4,626 | 3,246 | 4,455 | N/A |
| 9/30/2022 | 22,579 | 4,706 | 3,964 | 5,099 | N/A |
| 6/30/2022 | 21,620 | 4,781 | 3,894 | 4,913 | N/A |
| 3/31/2022 | 20,606 | 4,746 | 3,735 | 4,712 | N/A |
| 12/31/2021 | 19,857 | 4,896 | 4,272 | 5,209 | N/A |
| 9/30/2021 | 19,426 | 4,825 | 3,324 | 5,290 | N/A |
| 6/30/2021 | 18,916 | 4,561 | 3,102 | 5,023 | N/A |
| 3/31/2021 | 18,500 | 4,304 | 3,162 | 5,077 | N/A |
| 12/31/2020 | 18,570 | 4,241 | 3,003 | 4,941 | N/A |
| 9/30/2020 | 18,544 | 4,197 | 3,828 | 4,759 | N/A |
| 6/30/2020 | 18,572 | 3,949 | 3,876 | 4,842 | N/A |
| 3/31/2020 | 18,752 | 4,020 | 3,872 | 4,764 | N/A |
| 12/31/2019 | 18,330 | 3,974 | 3,833 | 4,615 | N/A |
| 9/30/2019 | 17,939 | 3,873 | 3,667 | 4,357 | N/A |
| 6/30/2019 | 17,555 | 4,119 | 3,599 | 4,161 | N/A |
| 3/31/2019 | 17,181 | 3,999 | 3,562 | 4,177 | N/A |
| 12/31/2018 | 16,815 | 3,896 | 3,522 | 4,126 | N/A |
| 9/30/2018 | 16,449 | 3,845 | 3,692 | 4,361 | N/A |
| 6/30/2018 | 16,195 | 3,816 | N/A | 4,370 | N/A |
| 3/31/2018 | 15,882 | 3,778 | N/A | 4,111 | N/A |
| 12/31/2017 | 15,728 | 3,791 | N/A | 4,004 | N/A |
| 9/30/2017 | 15,528 | 3,797 | N/A | 3,251 | N/A |
| 6/30/2017 | 15,287 | 3,211 | N/A | 2,994 | N/A |
| 3/31/2017 | 15,061 | 3,279 | N/A | 2,492 | N/A |
| 12/31/2016 | 14,780 | 3,264 | N/A | 2,653 | N/A |
| 9/30/2016 | 14,681 | 3,143 | N/A | 3,028 | N/A |
| 6/30/2016 | 14,563 | 1,297 | N/A | 3,081 | N/A |
| 3/31/2016 | 14,417 | 1,028 | N/A | 3,568 | N/A |
| 12/31/2015 | 14,264 | 927 | N/A | 3,320 | N/A |
| 9/30/2015 | 13,909 | 899 | N/A | 3,337 | N/A |
| 6/30/2015 | 13,502 | 3,162 | N/A | 3,119 | N/A |
| 3/31/2015 | 13,096 | 3,241 | N/A | 3,015 | N/A |
| 12/31/2014 | 12,666 | 2,407 | N/A | 3,193 | N/A |
| 9/30/2014 | 12,428 | 2,390 | N/A | 3,149 | N/A |
| 6/30/2014 | 12,184 | 2,298 | N/A | 3,177 | N/A |
| 3/31/2014 | 12,008 | 2,220 | N/A | 3,074 | N/A |
| 12/31/2013 | 11,833 | 2,874 | N/A | 3,270 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei COLO B ( 12.9% per jaar) ligt boven de spaarquote ( 1.2% ).
Winst versus markt: De winst van COLO B ( 12.9% per jaar) zal naar verwachting sneller groeien dan de Danish markt ( 11.6% per jaar).
Hoge groeiwinsten: De winst van COLO B zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van COLO B ( 7.8% per jaar) zal naar verwachting langzamer groeien dan de markt Danish ( 10% per jaar).
Hoge groei-inkomsten: De omzet van COLO B ( 7.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen COLO B zal naar verwachting over 3 jaar hoog zijn ( 35.2 %)